Journal of Pharmacy and Pharmacology · 1990 · 81 citations · 15 references
PharmacyBiochemistryPharmacologyBioavailabilityBioseparationsEndocytosisCell DisruptionCell-penetrating Delivery SystemsAsparaginase PharmacokineticsAsparaginase TherapyHalf-life DeterminationHalf-life Measurement
L-Asparaginase has been encapsulated in Swiss mouse or human erythrocytes by hypotonic haemolysis followed by isotonic resealing and reannealing. The details of incorporation and properties of carrier erythrocytes are presented. When L-asparaginase loaded into 51Cr-labelled erythrocytes, was infused intravenously, the same half-life was found for asparaginase and 51Cr. In addition, L-asparaginase loaded into erythrocytes was much more effective in eliminating plasma asparagine compared with the same dose of free L-asparaginase injected in solution, during a sustained period (14 days).
15
Toxicity of E. coli L-asparaginase in man
Herbert F. Oettgen, Phyllis A. Stephenson, Morton K. Schwartz et al. · Cancer · 1970 · 287 citations · Full text
Inhibition of leukemias in man by L-asparaginase.
Oettgen Hf, Old Lj, Boyse Ea et al. · PubMed · 1967 · 278 citations
Medicine, Oncology, Pharmacology +4
Toxicity of L-asparaginase in children with advanced leukemia
Vita J. Land, Wataru W. Sutow, Donald J. Fernbach et al. · Cancer · 1972 · 186 citations
Medicine, Oncology, Pharmacology +10